Compare iShares MSCI Japan ETF (EWJ) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Japan ETF vs Revvity Inc — how do they compare? iShares MSCI Japan ETF trades at $97.86 (market cap $23.87B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: iShares MSCI Japan ETF is the larger of the two by market cap, and Revvity Inc pays a 0.18% dividend while iShares MSCI Japan ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Japan ETF for 56 Days and Revvity Inc for 12 Days on average.
| EWJ | RVTY | |
|---|---|---|
Market Cap | $23.87B | $16.98B |
Volume | 5,412,820 | 1,456,900 |
Sector | Broad Market / Factor | Health |
52-Week High | $99.32 | $157.36 |
52-Week Low | $78.36 | $82.26 |
Typical Hold Time | 56 Days | 12 Days |
Enterprise Value | — | $19.30B |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $97.32, down 1.02% over the past day amid broader Asian market volatility. Technical indicators are mixed, with a neutral overall signal and bullish moving averages, while key support sits at $96. Recent news highlights Japan's monetary policy shifts, including BOJ rate hikes and yen fluctuations, influencing ETF performance as international equities show strength relative to the S&P 500.
The outlook for EWJ hinges on Japan's economic trajectory and central bank actions, with potential upside from continued international equity outperformance. Risks include rising bond yields, fiscal uncertainties, and currency volatility, warranting caution for investors seeking exposure to Japanese markets through this ETF.
RVTY trades at $152.16, down 0.94% today, near its recent 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent positive developments include a Zacks upgrade to Buy (2026-10-02) and the launch of a new Type 1 diabetes screening kit in Europe (Business Wire, 2026-09-24).
The outlook is positive, supported by earnings momentum and strategic expansions, but the stock's premium valuation (P/E of 73.15) and margin pressures pose risks. Analyst consensus is bullish with a $132.13 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
